216 related articles for article (PubMed ID: 22290095)
1. Anticoagulation and bleeding in patients with ventricular assist devices: walking the tightrope.
Kurien S; Hughes KA
AACN Adv Crit Care; 2012; 23(1):91-8. PubMed ID: 22290095
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
[TBL] [Abstract][Full Text] [Related]
4. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
[TBL] [Abstract][Full Text] [Related]
7. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices.
Suarez J; Patel CB; Felker GM; Becker R; Hernandez AF; Rogers JG
Circ Heart Fail; 2011 Nov; 4(6):779-84. PubMed ID: 22086831
[TBL] [Abstract][Full Text] [Related]
9. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
10. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience.
Hayes HM; Dembo LG; Larbalestier R; O'Driscoll G
Artif Organs; 2010 Sep; 34(9):703-6. PubMed ID: 20883388
[TBL] [Abstract][Full Text] [Related]
11. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients.
Gurvits GE; Fradkov E
World J Gastroenterol; 2017 Jun; 23(22):3945-3953. PubMed ID: 28652649
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy.
Barada K; Abdul-Baki H; El Hajj II; Hashash JG; Green PH
J Clin Gastroenterol; 2009 Jan; 43(1):5-12. PubMed ID: 18607297
[TBL] [Abstract][Full Text] [Related]
13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
14. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
15. Pulsatile vs. continuous flow in ventricular assist device therapy.
Loor G; Gonzalez-Stawinski G
Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):105-15. PubMed ID: 22910084
[TBL] [Abstract][Full Text] [Related]
16. Preexisting mitral valve prosthesis in patients undergoing left ventricular assist device implantation.
Schweiger M; Stepanenko A; Vierecke J; Drews T; Potapov E; Hetzer R; Krabatsch T
Artif Organs; 2012 Jan; 36(1):49-53. PubMed ID: 21951108
[TBL] [Abstract][Full Text] [Related]
17. [Endoscopy in patients receiving anticoagulation or antiplatelet therapy].
Kjeldsen J; Pless T; Meisner S; Bytzer P
Ugeskr Laeger; 2009 Apr; 171(17):1384-6. PubMed ID: 19413934
[TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
[TBL] [Abstract][Full Text] [Related]
19. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device.
Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC
J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468
[TBL] [Abstract][Full Text] [Related]
20. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices.
Shrode CW; Draper KV; Huang RJ; Kennedy JL; Godsey AC; Morrison CC; Shami VM; Wang AY; Kern JA; Bergin JD; Ailawadi G; Banerjee D; Gerson LB; Sauer BG
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1461-7. PubMed ID: 24480675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
